Skip to main content
Caplight Logo









Zehui Biotechnology

Zehui Biotechnology

Private
BeijingHealthcare & Life Scienceshttps://zephyrm.com/

Last Round

Series B

Mar 1, 2023

Est. Valuation

$327.56M

Total Funding Raised

$83.14M

Company Overview

Zehui Biotechnology is a biopharmaceutical company that develops innovative cell therapy products derived from pluripotent stem cells to treat various diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

pluripotent stem cellsPSCcell therapyregenerative medicinebiopharmaceuticalgraft-versus-host diseaseaGVHDclinical researchdrug developmentimmune regulationtissue regenerationbiotech startupclinical trialsstem cell researchcell therapy pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zehui Biotechnology Comparables

Compare Zehui Biotechnology with similar companies based on industry and business-model similarity.

Zehui Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Guangzhou Saijun Biotechnology Co., Ltd.
84%
Help Therapeutics
80%
iRegene Therapeutics
79%

Zehui Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 1, 2023
VC RoundApr 1, 2021
Series ADec 1, 2020
AngelSep 1, 2019

Zehui Biotechnology Investors

Notable investors and investment history

Zehui Biotechnology investors
InvestorRounds
Bencao CapitalVC Round
Guokejiahe FundVC Round
CAS StarAngel
CCB Trust Co., Ltd.Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2020

    $24M round led by Beijing Guoke Dingzhi Equity Investment Center.

  • Sep 1, 2019

    $14M raised from CAS Star.

Zehui Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zehui Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zehui Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Year Founded2017
Last FundingMar 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?